Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Hajime Kato, Hiroyasu Sato, Michiaki Okuda, Jun Wu, Shingo Koyama, Yasuhiko Izumi, Tomonori Waku, Mitsuyoshi Iino, Masashi Aoki, Shigeki Arawaka, Yasuyuki Ohta, Kenichi Ishizawa, Kanan Kawasaki, Yasuomi Urano, Tomohiro Miyasaka, Noriko Noguchi, Toshiaki Kume, Akinori Akaike, Hachiro Sugimoto & Takeo Kato. (2022) Therapeutic effect of a novel curcumin derivative GT863 on a mouse model of amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 23:7-8, pages 489-495.
Read now
Read now
John P. Franklin, Mimoun Azzouz & Pamela J. Shaw. (2020) SOD1-targeting therapies for neurodegenerative diseases: a review of current findings and future potential. Expert Opinion on Orphan Drugs 8:10, pages 379-392.
Read now
Read now
Arens Taga & Nicholas J. Maragakis. (2018) Current and emerging ALS biomarkers: utility and potential in clinical trials. Expert Review of Neurotherapeutics 18:11, pages 871-886.
Read now
Read now
Verena C Haringer & Summer B Gibson. (2015) Amyotrophic lateral sclerosis: clinical perspectives. Orphan Drugs: Research and Reviews 5, pages 19-31.
Read now
Read now
Articles from other publishers (26)
F.J. Arnold, A.D. Nguyen, R.S. Bedlack, C.L. Bennett & A.R. La Spada. (2023) Intercellular transmission of pathogenic proteins in ALS: Exploring the pathogenic wave. Neurobiology of Disease 184, pages 106218.
Crossref
Crossref
Zeynep YILDIRIM, Dicle Naz TOKTAŞ, Öznur DEMİR, Zülfiye GÜL & Burcu ŞEN UTSUKARÇİ. (2023) Amyotrofik Lateral Skleroz Patofizyolojisi ve Tedavi YaklaşımlarıAn Evaluation of Amyotrophic Lateral Sclerosis and Current Situation in Its Treatment. Hacettepe University Journal of the Faculty of Pharmacy.
Crossref
Crossref
Maruša Barbo & Metka Ravnik-Glavač. (2023) Extracellular Vesicles as Potential Biomarkers in Amyotrophic Lateral Sclerosis. Genes 14:2, pages 325.
Crossref
Crossref
Karin M. Forsberg, Karin S. Graffmo, Erica Stenvall, Naima Tabikh, Stefan L. Marklund, Thomas Brännström & Peter M. Andersen. (2022) Widespread CNS pathology in amyotrophic lateral sclerosis homozygous for the D90A SOD1 mutation. Acta Neuropathologica 145:1, pages 13-28.
Crossref
Crossref
L. McAlary, V.K. Shephard, G.S.A. Wright & J.J. Yerbury. (2022) A copper chaperone–mimetic polytherapy for SOD1-associated amyotrophic lateral sclerosis. Journal of Biological Chemistry 298:3, pages 101612.
Crossref
Crossref
Belgin Sever, Halilibrahim Ciftci, Hasan DeMirci, Hilal Sever, Firdevs Ocak, Burak Yulug, Hiroshi Tateishi, Takahisa Tateishi, Masami Otsuka, Mikako Fujita & Ayşe Nazlı Başak. (2022) Comprehensive Research on Past and Future Therapeutic Strategies Devoted to Treatment of Amyotrophic Lateral Sclerosis. International Journal of Molecular Sciences 23:5, pages 2400.
Crossref
Crossref
Andrea Barp, Amanda Ferrero, Silvia Casagrande, Roberta Morini & Riccardo Zuccarino. (2021) Circulating Biomarkers in Neuromuscular Disorders: What Is Known, What Is New. Biomolecules 11:8, pages 1246.
Crossref
Crossref
Maurits F. J. M. Vissers, Jules A. A. C. Heuberger & Geert Jan Groeneveld. (2021) Targeting for Success: Demonstrating Proof-of-Concept with Mechanistic Early Phase Clinical Pharmacology Studies for Disease-Modification in Neurodegenerative Disorders. International Journal of Molecular Sciences 22:4, pages 1615.
Crossref
Crossref
Ruben P. A. van Eijk, Marinus J. C. Eijkemans, Stavros Nikolakopoulos, Marc D. Jansen, Henk-Jan Westeneng, Kristel R. van Eijk, Rick A. A. van der Spek, Joke J. F. A. van Vugt, Sanne Piepers, Geert-Jan Groeneveld, Jan H. Veldink, Leonard H. van den Berg & Michael A. van Es. (2019) Pharmacogenetic interactions in amyotrophic lateral sclerosis: a step closer to a cure?. The Pharmacogenomics Journal 20:2, pages 220-226.
Crossref
Crossref
Luke McAlary, Steven S. Plotkin & Neil R. Cashman. (2019) Emerging Developments in Targeting Proteotoxicity in Neurodegenerative Diseases. CNS Drugs 33:9, pages 883-904.
Crossref
Crossref
Nick S. Verber, Stephanie R. Shepheard, Matilde Sassani, Harry E. McDonough, Sophie A. Moore, James J. P. Alix, Iain D. Wilkinson, Tom M. Jenkins & Pamela J. Shaw. (2019) Biomarkers in Motor Neuron Disease: A State of the Art Review. Frontiers in Neurology 10.
Crossref
Crossref
Tania Luthra, Akshay Kumar Nayak, Sarpita Bose, Saikat Chakrabarti, Ashish Gupta & Subhabrata Sen. (2019) Indole based antimalarial compounds targeting the melatonin pathway: Their design, synthesis and biological evaluation. European Journal of Medicinal Chemistry 168, pages 11-27.
Crossref
Crossref
Alex McCampbell, Tracy Cole, Amy J. Wegener, Giulio S. Tomassy, Amy Setnicka, Brandon J. Farley, Kathleen M. Schoch, Mariah L. Hoye, Mark Shabsovich, Linhong Sun, Yi Luo, Mingdi Zhang, Sai Thankamony, David W. Salzman, Merit Cudkowicz, Danielle L. Graham, C. Frank Bennett, Holly B. Kordasiewicz, Eric E. Swayze & Timothy M. Miller. (2018) Antisense oligonucleotides extend survival and reverse decrement in muscle response in ALS models. Journal of Clinical Investigation 128:8, pages 3558-3567.
Crossref
Crossref
Michael BenatarJoanne WuuPeter M. AndersenNazem AtassiWilliam DavidMerit CudkowiczDavid Schoenfeld. (2018)
Randomized, double-blind, placebo-controlled trial of arimoclomol in rapidly progressive
SOD1
ALS
. Neurology 90:7.
Crossref
Crossref
Loqman A. Mohamed, Shashirekha Markandaiah, Silvia Bonanno, Piera Pasinelli & Davide Trotti. (2017) Blood–Brain Barrier Driven Pharmacoresistance in Amyotrophic Lateral Sclerosis and Challenges for Effective Drug Therapies. The AAPS Journal 19:6, pages 1600-1614.
Crossref
Crossref
Ruben P.A. van EijkAshley R. JonesWilliam SprovieroAleksey ShatunovPamela J. ShawP. Nigel LeighCarolyn A. YoungChristopher E. ShawGabriele MoraJessica MandrioliGiuseppe BorgheroPaolo VolantiFrank P. DiekstraWouter van RheenenEsther VerstraeteMarinus J.C. EijkemansJan H. VeldinkAdriano ChioAmmar Al-ChalabiLeonard H. van den BergMichael A. van EsC Allen, C Counsell, A Farrin, A Al-Chalabi, B Dickie, J Kelly, P N Leigh, C L Murphy, C Payan, G Reynolds, P Shaw, I N Steen, M Thornhill, J Waters, J Zajicek, P N Leigh, A Al-Chalabi, P J Shaw, C A Young, M Thornhill, I N Steen, C L Murphy, K E Morrison, S Dhariwal, R Hornabrook, L Savage, D J Burn, T K Khoo, J Kelly, C L Murphy, A Al-Chalabi, A Dougherty, P N Leigh, L Wijesekera, M Thornhill, C M Ellis, R Ali, K O'Hanlon, J Panicker, L Pate, P Ray, L Wyatt, C A Young, L Copeland, J Ealing, H Hamdalla, I Leroi, C Murphy, F O'Keeffe, E Oughton, L Partington, P Paterson, D Rog, A Sathish, D Sexton, J Smith, H Vanek, S Dodds, T L Williams, I N Steen, J Clarke, C Eziefula, R Howard, R Orrell, K Sidle, R Sylvester, W Barrett, C Merritt, K Talbot, M R Turner, C Whatley, C Williams, J Williams, C Cosby, C O Hanemann, I Imam, C Phillips, L Timings, S E Crawford, C Hewamadduma, R Hibberd, H Hollinger, C McDermott, G Mills, M Rafiq, P J Shaw, A Taylor, E Waines, T Walsh, R Addison-Jones, J Birt, M Hare, T Majid, R. Tortelli, E. D'Errico, I. Bartolomei, E. Barbarossa, B. Depau, E. Costantino, E. D'Amico, A. Uncini, C. Manzoli, R. Quatrale, E. Sette, E. Montanari, M. Merello, D. Zarcone, M. Mascolo, M. Vignolo, S. Messina, C. Morelli, K. Marinou, L. Papetti, C. Lunetta, K. Gorni, D. De Cicco, C. Pipia, P. Sola, E. Georgoulopoulou, A. Sagnelli, G. Tedeschi, G. Oggioni, N. Nasuelli, C. D'Ascenzo, V. Cima, M. Aiello, R. Rizzi, E. Rinaldi, M. Luigetti, A. Conte, A. Torzini, G. Greco, R. Mutani, G. Fuda & M.A. Tommasi. (2017) Meta-analysis of pharmacogenetic interactions in amyotrophic lateral sclerosis clinical trials. Neurology 89:18, pages 1915-1922.
Crossref
Crossref
Dale J. Lange, Mona Shahbazi, Vincenzo Silani, Albert C. Ludolph, Jochen H. Weishaupt, Senda Ajroud-Driss, Kara G. Fields, Rahul Remanan, Stanley H. Appel, Claudia Morelli, Alberto Doretti, Luca Maderna, Stefano Messina, Ulrike Weiland, Stefan L. Marklund & Peter M. Andersen. (2017)
Pyrimethamine significantly lowers cerebrospinal fluid Cu/Zn superoxide dismutase in amyotrophic lateral sclerosis patients with
SOD1
mutations
. Annals of Neurology 81:6, pages 837-848.
Crossref
Crossref
Federica Rinaldi, Dario Motti, Laura Ferraiuolo & Brian K. Kaspar. (2017) High content analysis in amyotrophic lateral sclerosis. Molecular and Cellular Neuroscience 80, pages 180-191.
Crossref
Crossref
Taha Bali, Wade Self, Jingxia Liu, Teepu Siddique, Leo H Wang, Thomas D Bird, Elena Ratti, Nazem Atassi, Kevin B Boylan, Jonathan D Glass, Nicholas J Maragakis, James B Caress, Leo F McCluskey, Stanley H Appel, James P Wymer, Summer Gibson, Lorne Zinman, Tahseen Mozaffar, Brian Callaghan, April L McVey, Jennifer Jockel-Balsarotti, Peggy Allred, Elena R Fisher, Glenn Lopate, Alan Pestronk, Merit E Cudkowicz & Timothy M Miller. (2017) Defining SOD1 ALS natural history to guide therapeutic clinical trial design. Journal of Neurology, Neurosurgery & Psychiatry 88:2, pages 99-105.
Crossref
Crossref
Lucas T. Vu & Robert Bowser. (2016) Fluid-Based Biomarkers for Amyotrophic Lateral Sclerosis. Neurotherapeutics 14:1, pages 119-134.
Crossref
Crossref
Kristi M. Anderson & R. Lee Mosley. 2017. Neuroimmune Pharmacology. Neuroimmune Pharmacology
681
711
.
Jiyoun Lee. (2016) Mitochondrial drug targets in neurodegenerative diseases. Bioorganic & Medicinal Chemistry Letters 26:3, pages 714-720.
Crossref
Crossref
Mahlon A. Collins, Jiyan An, Brian L. Hood, Thomas P. Conrads & Robert P. Bowser. (2015) Label-Free LC–MS/MS Proteomic Analysis of Cerebrospinal Fluid Identifies Protein/Pathway Alterations and Candidate Biomarkers for Amyotrophic Lateral Sclerosis. Journal of Proteome Research 14:11, pages 4486-4501.
Crossref
Crossref
Nadine Bakkar, Ashley Boehringer & Robert Bowser. (2015) Use of biomarkers in ALS drug development and clinical trials. Brain Research 1607, pages 94-107.
Crossref
Crossref
Xenia Kobeleva & Susanne Petri. (2013) Barriers to novel therapeutics in amyotrophic lateral sclerosis. Neurodegenerative Disease Management 3:6, pages 525-537.
Crossref
Crossref
Allison S Limpert, Margrith E Mattmann & Nicholas D P Cosford. (2013) Recent progress in the discovery of small molecules for the treatment of amyotrophic lateral sclerosis (ALS). Beilstein Journal of Organic Chemistry 9, pages 717-732.
Crossref
Crossref